Today Truveta is excited to announce that the company is a finalist at the 2024 South by Southwest (SXSW) Innovation Awards recognizing Truveta Language Model (TLM) in the Artificial Intelligence (AI) category. This prestigious accolade not only acknowledges groundbreaking achievements but also celebrates the spirit of innovation across industries from the last year. Held annually as part of the SXSW Conference, the Innovation Awards highlight technological advancements and discoveries that push the boundaries of innovation.

Last year, Truveta announced TLM, a large-language, multi-modal AI model for transforming electronic health record (EHR) data into billions of clean and accurate data points for health research on patient outcomes with any drug, disease, or device. Unlike many other sectors, training AI models for healthcare demands the largest volume of real-time clinical data not widely available in public domains, and often raises the stakes in data privacy, security, and ethics. TLM’s healthcare expertise is trained on the largest collection of complete medical records representing the full diversity of the U.S. It is the first large-language model specifically designed to empower researchers to study all patient care and outcomes by utilizing Truveta Data.

Truveta has access to the volumes of AI data needed to expertly train AI

As the leader in real-world electronic health data, only Truveta has access to the volumes of EHR data needed to expertly train AI. Truveta is a growing health system collective providing more than 18% of all daily clinical care in the U.S. trusted by more than 50 leading healthcare and life science customers to study safety and effectiveness, improve patient care, and train medical AI. Across these leading organizations, Truveta connects data, people, and ideas to pursue a shared mission of Saving Lives with Data.

By normalizing EHR data to maximize clinical accuracy and being trained without commercial bias, TLM helps to ensure research is conducted with data focused on clinical outcomes, not billing. TLM combines pre-trained open large language models with additional training on the most representative clinical data set to achieve over 90 percent accuracy on diagnoses, medications, lab results, clinical observations, and more. Using clean, de-identified data from health system members, TLM is trained upon input representing more than 100 million patient journeys, including 5.5 billion diagnoses, 3.1 billion encounters, and 2.4 billion medication orders.

With AI innovations like TLM, life science teams can study concepts previously inaccessible in messy clinician notes

Early research and insights from Truveta on topics like prescribing trends for GLP-1 RA medications, preeclampsia and maternal heart health, comparative effectiveness of GLP-1 RA medications like Ozempic and Mounjaro, and respiratory virus hospitalization trends among many other topics, are showing the power of clean, complete data to improve patient care and advance health equity.

Truveta’s community of healthcare and life science customers are currently studying concepts previously inaccessible in messy clinician notes because of TLM. These notes are often extremely long and detailed, ranging from progress notes and discharge summaries to lab reports and transcribed telephone encounters. With AI innovations, like TLM, this lengthy process is getting some much-needed innovation.

Importantly, life sciences, healthcare systems, academic medical centers, research institutes and government agencies, like the Centers for Disease Control and Prevention, are validating this AI innovation by choosing Truveta to enable scientifically rigorous research with regulatory-grade data and powerful analytics. Today, Truveta’s innovative technology solutions are trusted by organizations like Pfizer, Moderna, Boston Scientific, Boehringer Ingelheim, Reprieve Cardiovascular, SK Life Science and many more.

Truveta is honored to be recognized by the SXSW Innovation Awards

Truveta is honored to be recognized by the SXSW Innovation Awards as a finalist. Truveta will exhibit TLM and the company’s AI work  to judges and conference attendees at the Innovation Awards Finalist Showcase during SXSW on Saturday, March 9. Winners will be announced at the SXSW Innovation Award Ceremony  Monday, March 11 in Austin, Texas.

This ceremony serves as a grand celebration of the visionaries and trailblazers who have made significant contributions to the world of technology.  

Attending SXSW in 2024? Visit Truveta in the conference center or contact us to meet in Austin.

Learn more and request a demo: Contact Us – Demo | Truveta